NAFLD Fibrosis Score (NFS)
iatroX editorial team · Updated · Record checked · editorial policy
The NAFLD Fibrosis Score is a non-invasive composite score predicting advanced liver fibrosis (F3–F4) in patients with NAFLD/MASLD. It uses age, BMI, diabetes status, AST/ALT ratio, platelets, and albumin.
inputs
evidence
derivation
Developed by Angulo et al. (Hepatology 2007) from a cohort of 733 biopsy-proven NAFLD patients across multiple centres.
validation
AUROC 0.82–0.88 for advanced fibrosis. The low cut-off (<−1.455) has NPV ~93%, making it effective for ruling out advanced fibrosis. Validated in multiple independent NAFLD cohorts internationally.
guideline endorsements
NICE NG49 references NFS alongside FIB-4. EASL NAFLD/MASLD guidelines 2024 recommend FIB-4 or NFS as first-line non-invasive tests. AASLD NAFLD guidance references NFS.
references
- Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846-854.PMID: 17393509
- NICE Guideline NG49. Non-alcoholic fatty liver disease: assessment and management. 2016.link ↗
- Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966-1986.PMID: 37363821